KPTI
Karyopharm TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
KPTI vs peer average
65/100
KPTI vs. peer average (C vs. D)
Grade spread
A 1 · B 1 · C 2 · D 1 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ATRA is the first available peer comparator.
Atara is another sub-scale biotech where financing durability and catalyst timing dominate equity value; it is more of an event-risk comp than a science or indication match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KPTI
Karyopharm Therapeutics
ATRA
Atara Biotherapeutics
Grade
C
A
Momentum
58
95
Value
41
60
Sentiment
53
37
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ATRA
KPTI / ATRA
Grade Position
In line
KPTI vs. peer average (C vs. D)
65/100
Momentum
58
ATRAValue
41
ATRASentiment
53
KPTIRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KPTI
ATRA is the first peer returned for this comparison set.